中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

21 records (took 0.015 seconds)

    Exercise triggered cardiovascular pressure measurement
    1.
    发明授权
    Exercise triggered cardiovascular pressure measurement 有权

    公开(公告)号：US10376159B2

    公开(公告)日：2019-08-13

    申请号：US15384709

    申请日：2016-12-20

    Applicant: Medtronic, Inc.

    Inventor： Mary M. Morris ,  Ruth N. Klepfer ,  Karen J. Kleckner ,  Joel R. Lauer

    IPC: A61B5/0205 ,  A61B5/0215 ,  A61B5/00 ,  A61B5/11 ,  A61N1/365 ,  A61N1/39 ,  G16H40/63 ,  G16H20/30 ,  A61B5/024 ,  A61B5/08

    Abstract: Systems, devices disclosed provide example methods comprising determining that a triggering event has occurred based on statuses for a set of physiological parameters associated with the patient, the physiological parameters indicative of the patient engaging in a patient initiated physical activity, generating a trigger output signal in response to the determination that the triggering event has occurred, wirelessly transmitting the trigger output signal to a pressure sensing device implanted in a vessel of the patient, triggering, based on receiving the trigger output signal, the pressure sensing device to sense a cardiovascular pressure of the patient; and transmitting, by the pressure sensing device, a wireless signal comprising data corresponding to the sensed cardiovascular pressure of the patient.

    MEASURING CARDIOVASCULAR PRESSURE BASED ON PATIENT STATE
    5.
    发明申请
    MEASURING CARDIOVASCULAR PRESSURE BASED ON PATIENT STATE 审中-公开

    公开(公告)号：US20200288989A1

    公开(公告)日：2020-09-17

    申请号：US16885396

    申请日：2020-05-28

    Applicant: Medtronic, Inc.

    Inventor： Mary M. Morris ,  Ruth N. Klepfer ,  Karen J. Kleckner ,  Joel R. Lauer

    IPC: A61B5/0215 ,  A61B5/00

    Abstract: A method for monitoring a cardiovascular pressure in a patient includes measuring, by pressure sensing circuitry of an implantable pressure sensing device, the cardiovascular pressure of the patient. The method further includes transmitting, via wireless communication circuitry of the implantable pressure sensing device, the measured cardiovascular pressure to another device. The method further includes determining, by processing circuitry of the other device, whether a posture of the patient at a time of the measured cardiovascular pressure was a target posture for cardiovascular pressure measurements. The method further includes determining, by the processing circuitry of the other device, whether to store or discard the transmitted cardiovascular pressure based on determining whether the posture was the target posture.

    Controlling drug delivery transitions
    6.
    发明授权
    Controlling drug delivery transitions 有权
    控制药物转运

    公开(公告)号：US09314572B2

    公开(公告)日：2016-04-19

    申请号：US14077069

    申请日：2013-11-11

    Applicant: Medtronic, Inc.

    Inventor： Mary M. Morris ,  Mark A. Bellrichard ,  Robert Garfield ,  Daniel Gelfman ,  Lu Wang ,  Michael W. Kimmel ,  Karen J. Kleckner ,  Brian W. Ball

    IPC: A61M5/172 ,  A61M5/142 ,  G06F19/00 ,  A61M5/14 ,  A61M5/168

    CPC classification number: A61M5/172 ,  A61M5/1407 ,  A61M5/142 ,  A61M5/14244 ,  A61M5/168 ,  A61M5/16827 ,  A61M2205/3379 ,  A61M2205/52 ,  G06F19/00 ,  G06F19/3468

    Abstract: Devices, systems, and techniques for transitioning between different drug delivery sources or different drug concentrations may account for diffusion and mixing of drug within the fluid. In one example, a method may include determining a flow rate for a fluid to be delivered to a patient via a drug pump and a catheter in fluid communication with a reservoir of the drug pump. The fluid includes a drug. The method also includes determining a concentration profile of the drug delivered via the catheter, wherein the concentration profile identifies a volume of delivered fluid needed to achieve a target transition dose of the drug. The method further includes determining, by a processor and based on the flow rate and the concentration profile, an initial delivery period required to achieve the target transition dose by delivering the fluid at the flow rate.

    Abstract translation: 用于在不同药物递送源或不同药物浓度之间转换的装置，系统和技术可以解释药物在流体内的扩散和混合。 在一个示例中，方法可以包括通过药物泵和与药物泵的储存器流体连通的导管确定要输送给患者的流体的流速。 流体包括药物。 该方法还包括确定通过导管递送的药物的浓度分布，其中浓度分布图识别实现药物的目标转换剂量所需的递送液体的体积。 该方法还包括由处理器根据流速和浓度分布来确定通过以流速输送流体来实现目标转变剂量所需的初始输送周期。

    SENSATION MANAGEMENT
    7.
    发明申请
    SENSATION MANAGEMENT 有权

    公开(公告)号：US20250018207A1

    公开(公告)日：2025-01-16

    申请号：US18765497

    申请日：2024-07-08

    Applicant: Medtronic, Inc.

    Inventor： Amy E. Thompson-Nauman ,  Matthew J. Hoffman ,  Vladimir P. Nikolski ,  Mary M. Morris

    IPC: A61N1/39 ,  A61N1/05 ,  A61N1/32 ,  A61N1/36 ,  A61N1/365

    Abstract: In some examples, a medical device includes an elongated structure configured to extend from an access point of a patient through an intercostal space within the patient. The medical device may further include a plurality of electrodes comprising a first subset of electrodes and a second subset of electrodes, where at least the first subset of electrodes is carried on a distal portion of the elongated structure. The first subset of electrodes of the plurality of electrodes may be configured to deliver electrical therapy to a heart of the patient or sense cardiac activity. The second subset of electrodes of the plurality of electrodes may be configured to deliver energy to tissue proximate a ribcage of the patient to reduce a sensation in one or more intercostal nerves.

    IMPLANTABLE MEDICAL LEAD
    9.
    发明申请
    IMPLANTABLE MEDICAL LEAD 有权

    公开(公告)号：US20220023621A1

    公开(公告)日：2022-01-27

    申请号：US17378486

    申请日：2021-07-16

    Applicant: Medtronic, Inc.

    Inventor： Ronald A. Drake ,  Mary M. Morris ,  McKenna Rose Redmond Del Toro ,  Megan L. Platner ,  Kaileigh E. Rock ,  Brian P. Colin ,  William Eastman

    IPC: A61N1/05

    Abstract: An implantable medical lead comprising a lead body defining a lumen. The lead body includes one or more tines substantially at a distal end of the lead body. An inner member extending within the lead body lumen is configured to rotate relative to the lead body and configured to cause a rotation of a dilator. The dilator is configured such that the rotation causes or enables a lateral translation of the dilator from a first position proximal to a lead body opening to a second position distal to the lead body opening. The implantable medical lead may include a probe wire configured to slidably translate through an inner lumen of the dilator.

Patent Agency Ranking